Elan Pharmaceuticals (ELN) Reports Second Quarter and First Half 2013 Financial Results
7/24/2013 6:35:25 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Elan Corporation, plc (NYSE:ELN) today reported its second quarter and first half 2013 financial results.
“We are focused squarely on the process of exploring a sale of the company as announced by our Board of Directors on June 14, 2013,” commented Mr. Kelly Martin, CEO, adding, “the Board of Directors and executive management are in complete alignment with regard to exploring all opportunities to maximize shareholder value.”
Help employers find you! Check out all the jobs and post your resume.